Cordis J and J shakeup with more executive departures

Cordis J & J announced the departure of worldwide president Tom Pope, the seventh in a string of executives to leave during an uncertain period for coronary stent technology. As reported by Forbes.com, this occurs under the circumstances of Abbott Medical's strong showing with the Xience stent which outperformed the Taxus stent from Boston Scientfic. It is predicted that Abbott will control 47% of the market by 2011 by Wachovia analyst Larry Biegelson.